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Caspase-1 Activation: More
Common among
Enteropathogens than We
Thought?
Caspase-1 is an important converging
point for danger signals initiating inflam-
mation and defense. Recent work suggests
that RhoGTPase activation and/or cyto-
skeletal disturbance may represent a novel
pathway eliciting caspase-1 responses that
are subverted by several enteropathogenic
bacteria. The enteropathogen Salmonella
Typhimurium employs the type III effector
protein SopE, an activator (guanine nucle-
otide exchange factor [GEF]) for RhoGT-
Pases, to elicit caspase-1 maturation and
release of the pro-inflammatory cytokine
IL-1b to trigger gut inflammation in vivo.
Recently, a whole new family of pathogen-
encoded RhoGTPase GEFs has been
discovered, including Map, IpgB1, and
IpgB2 from enteropathogenic Escherichia
coli and Shigella spp.. We will discuss the
evidence suggesting that these virulence
factors may also activate caspase-1 signal-
ing.
Caspase-1 Integrates Multiple
Danger Signals
Mucosal surfaces are constantly exposed
to a large number of commensal, non-
pathogenic microorganisms towards which
the gut immune system remains non-
responsive [1]. In the case of an acute
infection, this homeostasis is overruled and
an inflammatory response is initiated.
Detection of pathogen-derived molecules,
bacterial growth, or other ‘‘danger sig-
nals’’ indicating infection or trauma occurs
via ‘‘pattern recognition receptors’’ and
other detectors on the surface and in the
cytosol of mucosal cells and most other
cells of the body [2,3]. This detection
process induces the production of pro-
inflammatory cytokines, which initiate the
innate immune defense. Caspase-1 repre-
sents an important converging point for
processing danger signals: physical stress,
pore-forming toxins, extracellular ATP,
and the presence of conserved bacterial
products (e.g., flagellin or peptidoglycan)
in the cytosol are detected via danger-
sensing molecules and adaptors [4]. These
bind to caspase-1 and lead to the forma-
tion of multiprotein complexes called
inflammasomes [5]. Thereby, caspase-1
is activated and catalyzes the maturation
and release of pro-inflammatory cyto-
kines like interleukin (IL)-1b and IL-18
(Figure 1A). Thus, caspase-1 activation is a
central regulator of the innate immune
defense. Recent work has indicated that
the activation of RhoGTPases, in partic-
ular Rac1 and possibly Cdc42, might
represent a novel type of signaling input
that can activate caspase-1 signaling and
which may represent a point of attack for
bacterial virulence factors (Figure 1A,
right, [6–8]).
SopE, a Potent Activator of Host
Cellular RhoGTPases
SopE from the enteropathogenic bacte-
rium Salmonella enterica subspecies I serovar
Typhimurium (S. Typhimurium) is a well-
known functional mimic of mammalian
GEFs [9]. SopE is delivered into host cells
via the bacterial type III secretion system-
1 (TTSS-1), binds to host cellular RhoGT-
Pases, including Rac1 and Cdc42, and
activates them by catalyzing rapid G-
nucleotide exchange [9,10].
The activity of cellular RhoGTPases
depends on guanine nucleotide binding
and is regulated by various cellular
proteins. Rho-specific cellular GEFs stim-
ulate the nucleotide exchange on RhoGT-
Pases. Upon release of GDP and subse-
quent binding of GTP, the RhoGTPase
switches to its active conformation and is
now able to signal to downstream effectors
[11]. By mimicking the function of endog-
enous GEFs, SopE disturbs the RhoGT-
Pase activation cycle and initiates signal-
ing downstream of Rac1 and Cdc42,
respectively [9].
SopE is the prototype of a family of
bacterial RhoGTPase GEFs that also
includes SopE2 and BopE from Salmonella
and Burkholderia spp. (Table 1, Figure 2A).
In spite of the functional similarity, SopE-
like GEFs have an entirely different three-
dimensional structure than the Dbl-like
mammalian GEFs for RhoGTPases
(Figure 2B, [12]). SopE is composed of
two three-helix bundles and a small GA-
rich loop in the catalytic center. Nonethe-
less, several amino acid contacts with the
RhoGTPase and the basic catalytic mech-
anism are shared with Dbl-like mammali-
an GEFs [12,13]. Moreover, both GEF
families bind to the same surface of the
RhoGTPase, i.e., the ‘‘switch 1’’ and
‘‘switch 2’’ regions that facilitate G-
nucleotide binding [12,14]. Thus, SopE-
like GEFs of pathogenic bacteria are
‘‘functional mimics’’ of host cellular Dbl-
like GEFs.
Caspase-1 Activation by SopE
SopE is one of the key TTSS-1 effectors
driving host cell invasion and the induction
of mucosal inflammation by S.T y p h i m u r -
ium [9,15–17]. SopE was shown to induce a
number of host cell responses, including the
activation of JNK and PAK signaling and
prominent actin cytoskeleton rearrange-
ments [9,18]. Therefore, it has been assumed
that SopE- and RhoGTPase-mediated tissue
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sufficient to explain how SopE contributes to
gut inflammation. However, recent work has
identified a different biological mechanism:
SopE-mediated RhoGTPase activation was
found to drive not only tissue invasion, but
also caspase-1 activation and the release of
IL-1b (Figure 1A, right [8]). Caspase-1 was
also activated in cells over-expressing consti-
tutively active Rac1, constitutively active
Cdc42, or an active mutant of the Dbl-like
Rac1-GEF Tiam1 [6,8]. Moreover, knock-
out mice lacking caspase-1/IL-1/IL-18 re-
sponses still allowed SopE-mediated tissue
invasion, but failed to mount mucosal
inflammation. In bone marrow chimaeric
mice, caspase-1 was required primarily
within stromal cells of the gut mucosa, most
likely enterocytes [8]. Together, these data
indicated that GEF-induced RhoGTPase
activation in the mucosal epithelium can
elicit caspase-1/IL-1b/IL-18-dependent gut
inflammation.
A New Family of Bacterial GEFs
Recently, a second family of bacterial
type III effector proteins, the WxxxE
family, was found to possess GEF activity
for host cellular RhoGTPases [19]. The
WxxxE family includes Map from entero-
pathogenic E. coli (EPEC), IpgB1 and
IpgB2 from Shigella, and SifA and SifB
from Salmonella spp.. These proteins harbor
a unique flexible loop in the catalytic site
and an invariant WxxxE motif (Figure 2A).
Although phylogenetically unrelated to
SopE-like GEFs, the WxxxE family GEFs
display a protein fold that is highly similar
to that of SopE/E2 and employ the same
catalytic mechanism (Figure 2B). Several
WxxxE family members, e.g., Map, IpgB1,
and IpgB2, have been shown to induce
RhoGTPase activity [19]. Interestingly,
they differ in their substrate specificities
(Table 1, [19,20]). For example, in vivo,
IpgB1 activates Rac1 and Cdc42 [21],
whereas IpgB2 preferentially activates
RhoA, but also Cdc42 and Rac1 in vitro
[19]. This observation suggests that, de-
pending on the preferred target, at least a
subset of WxxxE GEFs might serve similar
functions as SopE in pro-inflammatory
signaling.
Caspase-1: An Achilles’ Heel
Subverted by Mucosal
Pathogens?
The vast majority of SopE or WxxxE
family type III effector proteins have been
detected in enteropathogenic bacteria
(Table 1). In the case of SopE, GEF-
induced RhoGTPase activation was
shown to elicit caspase-1 responses and
the release of caspase-1-dependent cyto-
kines, i.e., IL-1b and IL-18, thus leading to
gut inflammation [8]. Based on these data,
we hypothesize that the WxxxE family
members found in enteropathogenic E. coli
and Shigella spp. may have the same
biological function, i.e., activating cas-
pase-1 in the host’s intestine. Among these
effector proteins, GEFs with specificity for
Rac1 and Cdc42 are especially good
candidates to activate caspase-1, since
Figure 1. Danger-associated signaling via the inflammasome. (A) Cytosolic microbe-
associated molecular patterns and danger signals are detected and integrated by an array of
inflammasome components converging at the activation of caspase-1 [5,38–40]. In addition to
the already known stimuli for inflammasome activation (left, red), a pathway involving S.
Typhimurium SopE and Rho GTPases (right, blue) has been described recently [8]. (B) Comparison
of the virulence mechanisms of Salmonella spp., Shigella spp., and Citrobacter/EPEC. The effector
proteins injected can act both directly on the actin polymerization as well as via the activation of
Rho GTPases [41–43]. (C) Comparison of pathologies in different animal models of Salmonella,
Shigella, and Citrobacter/EPEC infection. The region of the strongest pathology and the most
important pathological changes in each model is indicated in red. Representative images for the
macroscopic and histological changes in the respective animal models can be found in references
[44–48].
doi:10.1371/journal.ppat.1000795.g001
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Cdc42) has been shown to activate cas-
pase-1 [6]. Thus, GEF-mediated caspase-1
activation might be a common strategy of
enteropathogenic bacteria for enhancing
mucosal inflammation (Figure 1B). This is
of special significance in light of earlier
work on Salmonella and Citrobacter infection
models showing that enteropathogenic
bacteria can benefit from eliciting gut
inflammation: although some aspects of
the pathology differ between the model
systems (e.g., proximal/distal location of
the most severe lesions in the large
intestine Figure 1C), the host’s inflamma-
tory response is thought to suppress
growth of the competing commensal
microflora in either case [22–24]. There-
fore, it is tempting to speculate that
virulence factors with Rac1- and/or
Cdc42-specific GEF activity might allow
enteropathogens to subvert Rho GTPase-
mediated caspase-1 activation in order to
gain an edge against the commensal
microflora.
Analysis of Caspase-1
Activation by Bacterial Effector
Proteins—A Tricky Task
In principle, knockout mice deficient in
caspase-1, IL-18, or IL-1 signaling allow
the analysis of caspase-1 activation by
candidate virulence factors. However, this
analysis is tricky for two different reasons.
First, caspase-1 activation and IL-1/
IL-18 signaling represent an important
arm of the innate immune defense
(Figure 1A) which helps to clear pathogens
and limits further pathogen-inflicted dam-
age [25–29]. Therefore, caspase-1, IL-1,
or IL-18 deficiency tends to increase
pathogen loads in infected tissues, can
trigger additional (caspase-1/IL-1/IL-18
independent) pro-inflammatory pathways
and amplify disease symptoms. This phe-
notype has been observed in Shigella
and Citrobacter infection experiments and
may have masked WxxxE protein-induced
effects [25,30].
Second, there is appreciable functional
overlap between the Shigella, Salmonella,
and EPEC virulence factors inducing
mucosal inflammation. Not all of them
require caspase-1 [8,31]. Therefore, the
contribution of caspase-1-dependent viru-
lence factors may be ‘‘masked’’ in wild-
type infections, as was shown to be the
case in Salmonella infections [8,28]. The
investigation of virulence factors activating
caspase-1 thus requires knowledge about
functionally overlapping pro-inflammatory
mechanisms. These would have to be
disrupted in order to unequivocally iden-
tify (or refute) a caspase-1-mediated viru-
lence mechanism.
Thus, in the case of pathogens employ-
ing SopE or WxxxE family effector pro-
teins, caspase-1, IL-1, or IL-18 deficiency
Table 1. Guanine Nucleotide Exchange Factors Involved in Pathogenesis and/or Caspase-1 Activation.
Effector Pathogen/Organism
Host Model
System (for
In Vivo Phenotype)
Activated
Target
GTPasea
Caspase-1
Activation
Shown Pathology
Virulence Defect
of GEF Mutant Reference
In Vitro In Vivo
SopE-type bacterial GEFs
BopE Burkholderia
pseudomallei
Murine systemic
infection
Cdc42, Rac1 Abscess formation
(melioidosis)
b
++[49–51]
SopE Salmonella enterica Murine enterocolitis,
bovine ileal loops
Rac1, Cdc42 + Gut inflammation ++[8,9,15,17,31,52]
SopE2 Salmonella enterica Murine enterocolitis,
bovine ileal loops
Cdc42 (Rac1) +
c Gut inflammation ++[8,17,52–54]
WxxxE-type bacterial GEFs
EspM1
d Enteropathogenic
Escherichia coli
Unknown Attaching/effacing
lesions
+ [55]
EspM2/3
d Citrobacter rodentium,
enteropathogenic
Escherichia coli
RhoA Attaching/effacing
lesions
+ [55]
EspT
d Enteropathogenic
Escherichia coli
Rac1, Cdc42 Attaching/effacing
lesions
+ [56]
IpgB1 Shigella flexneri Murine lung infection Rac1 (Cdc42) Bacterial dysentery ++
e [19,21,57]
IpgB2 Shigella flexneri Murine lung infection RhoA (Rac1, Cdc42) Bacterial dysentery ++
e [19,20,57]
Map
f Citrobacter rodentium,
enteropathogenic
Escherichia coli
Murine enterocolitis Cdc42 Attaching/effacing
lesions
++[19,20,58,59]
SifA
d Salmonella enterica RhoA Gut inflammation + [60]
Dbl-type eukaryotic GEFs
Tiam1 Human Rac1 (Cdc42) +
c [8,61]
aFor some effector proteins, the Rho GTPase specificity has not been analyzed in sufficient detail; therefore, specificity for additional Rho GTPases not listed is likely for
some of the GEFs.
bB. pseudomallei causes a wide variety of disease symptoms among different hosts, including pneumonia, gut inflammation, and diarrhea [62].
cUpon transfection.
dSequence homology data and GEF activity not directly shown.
eIpgB1 and IpgB2 were shown to cooperatively contribute to the in vivo phenotype.
fC. rodentium and enteropathogenic E. coli share highly homologous forms of Map [63]. The in vivo phenotype was shown with C. rodentium Map, whereas GEF activity
was shown experimentally with E. coli Map.
doi:10.1371/journal.ppat.1000795.t001
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ing the responsiveness towards the cas-
pase-1-activating virulence factor versus
increasing pathogen loads (and possibly
damage) in the host’s tissue. Therefore,
the experiments need to be designed
carefully in order to discern these oppos-
ing effects. For example, SopE-mediated
caspase-1 activation was clearly observed
in S. Typhimurium strains lacking other
virulence factors, but it was masked in the
context of the wild-type pathogen [8,28].
A similar balance between caspase-1-
mediated innate defense and pathogen-
induced pathology may have prohibited
unequivocal detection of WxxxE protein-
mediated caspase-1 activation in the cases
of Shigella spp., Citrobacter spp., or entero-
pathogenic E. coli [30]. Pathogen mutants
stripped of all but the caspase-1-depen-
dent virulence factor protein, effector
protein expression in a Salmonella mutant
stripped of all relevant effector proteins,
or tissue culture transfection experiments
might help to circumvent this technical
problem.
The RhoGTPase–Caspase-1
Connection: What’s in Between?
In HEK293 cells, Rac1 and Cdc42
activation is sufficient for activating cas-
pase-1 [6,8]. However, it has remained
unclear whether a specific downstream
effector protein of Rac1 and/or Cdc42 or
disturbance of the actin cytoskeleton
inflicted by the activated RhoGTPases
transmits the danger signal towards cas-
pase-1. The Rac1 effector kinase LIMK
was suggested to be involved in signaling
Figure 2. Sequence and structural comparison of GEFs from different origins. (A) Sequence alignment of SopE-type (upper alignment) and
WxxxE-type (lower alignment) bacterial effector proteins with postulated Rho GTPase activity; .80% identity is shaded in red, .50% in grey. The
residues shown to be important for catalytic GEF activity of SopE [13] or Map [19] are marked with asterisks. WxxxE motif and catalytic loops
highlighted in (B) are marked with brackets. Note that SifA has a completely different amino acid sequence in its catalytic loop compared to the other
proteins in the WxxxE family [19]. (B) Crystal structures of GEFs from different organisms in complex with Cdc42 (orange). Left panel: SopE (cyan) from
S. Typhimurium [12]; the catalytic loop is highlighted in red. Middle panel: Map (pink) from enteropathogenic E. coli [19]; the WxxxE motif is
highlighted in blue and the catalytic loop in red. Right panel: Human Tiam1 (pale blue); only the Rho GTPase binding DH domain is shown [14].
Structures were created using Jmol (http://www.jmol.org/).
doi:10.1371/journal.ppat.1000795.g002
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caspase-1 with and phosphorylation by
PAK-1 was shown [32]. Other reports
support a role for actin and actin-binding
proteins. The gelsolin family protein
flightless-I binds and inhibits caspase-1,
thereby possibly linking caspase-1 activity
to the actin cytoskeleton [33]. In macro-
phages, inflammasome components might
be sequestered by perinuclear F-actin
structures that form upon certain inhibi-
tory stimuli [34]. The molecular links
between Rac1/Cdc42 and inflammasome
activation remain to be elucidated.
An Evolutionary Role for
Linking Actin Polymerization to
Caspase-1 Activation
The detection of microbe-associated
molecular patterns alone is not sufficient
to induce an inflammatory response in the
gut mucosa. Additional signals character-
istic of pathogen growth within a tissue or
other trauma are thought to be required
before the innate immune system re-
sponds. A prominent example of such a
two-layered control mechanism is the pro-
inflammatory cytokine IL-1b. Pro-IL-1b
expression is induced upon TLR4 stimu-
lation by bacterial lipopolysaccharide
(LPS). However, the pro-IL-1b has to be
cleaved and activated by caspase-1 before
it is secreted [35]. Caspase-1 in turn is
activated in response to numerous danger
signals [36]. Manipulation or disruption of
the cell cytoskeleton has been proposed
recently as a ‘‘pattern of pathogenicity’’
signal that feeds into caspase-1 activation
and pro-IL-1b processing [37]. Based on
this, it is tempting to speculate that Rac1/
Cdc42 activation or actin disturbance itself
might represent a pathogen-associated
danger signal sensed by the innate im-
mune system. If this held true, the SopE
and WxxxE families of type III effector
proteins might subvert a pathogen-sensing
mechanism for eliciting mucosal inflam-
mation. With knockout mice deficient in
caspase-1 and several inflammasome com-
ponents and a growing number of useful
infection models at hand, investigating the
involvement of WxxxE GEFs in caspase-1
activation will be an interesting task for
future research.
Accession Numbers
The UniProt (http://www.uniprot.org/
uniprot/) accession numbers for the protein
sequences used for alignment in Figure 2A
are O52623 (S. enterica sv. Typhimurium
SopE), Q7CQD4 (S. enterica sv. Typhimur-
ium SopE2), Q63K41 (B. pseudomallei BopE),
C6URF9 (E. coli EspM2), B5YYM1 (E. coli
EspM3), B1GVN9 (C. rodentium EspM3),
Q8VQ34 (E. coli EspM1), Q9AJW7 (S.
flexneri IpgB2), B9WN88 (E. coli EspT),
Q7DB76 (E. coli Map), Q6XVY7 (S. flexneri
IpgB1), and Q56061 (S. enterica sv. Typhi-
murium SifA).
The PDB (http://www.rcsb.org/pdb/)
accession codes for the structures shown in
Figure 2B are 1gzs for SopE [12], 3cgc for
Map [19], and 1foe for Tiam1 [14].
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